Aurinia Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

CEO

Peter S. Greenleaf

CEOPeter S. Greenleaf

Employees

130

Employees130

Headquarters

Edmonton, Alberta

HeadquartersEdmonton, Alberta

Founded

1993

Founded1993

Employees

130

Employees130

AUPH Key Statistics

Market cap

1.45B

Market cap1.45B

Price-Earnings ratio

30.73

Price-Earnings ratio30.73

Dividend yield

—

Dividend yield—

Average volume

2.12M

Average volume2.12M

High today

$13.54

High today$13.54

Low today

$10.34

Low today$10.34

Open price

$13.17

Open price$13.17

Volume

7.83M

Volume7.83M

52 Week high

$13.54

52 Week high$13.54

52 Week low

$6.55

52 Week low$6.55

AUPH News

TipRanks 50m

Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Sherwood News 6h

Pharma company Aurinia falls after FDA official uses LinkedIn to call out lupus drug

Aurinia Pharmaceuticals dropped on Monday after a Food and Drug Administration official criticized a method of evaluating drugs that was used to approve the com...

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell

People also own

Based on the portfolios of people who own AUPH. This list is generated using Robinhood data, and it’s not a recommendation.